These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Preservation of renal function during maintenance therapy with cyclosporine. Serón D; Moreso F Transplant Proc; 2004 Mar; 36(2 Suppl):257S-260S. PubMed ID: 15041349 [TBL] [Abstract][Full Text] [Related]
10. Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants. John U; Ullrich S; Roskos M; Misselwitz J Transplant Proc; 2005 Apr; 37(3):1608-11. PubMed ID: 15866686 [TBL] [Abstract][Full Text] [Related]
11. Experience with cyclosporine in the Canary Islands. Hernández D Transplant Proc; 2004 Mar; 36(2 Suppl):120S-124S. PubMed ID: 15041320 [TBL] [Abstract][Full Text] [Related]
12. The impact of cyclosporine on the development of immunosuppressive therapy--pediatric transplantation using cyclosporine. Hoyer PF; Vester U Transplant Proc; 2004 Mar; 36(2 Suppl):197S-202S. PubMed ID: 15041336 [TBL] [Abstract][Full Text] [Related]
13. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250 [TBL] [Abstract][Full Text] [Related]
14. Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity. Shang MH; Yuan WJ; Zhang SJ; Fan Y; Zhang Z Chin Med J (Engl); 2008 Jun; 121(11):983-8. PubMed ID: 18706245 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporine: from renal transplantation to autoimmune diseases. Ponticelli C Ann N Y Acad Sci; 2005 Jun; 1051():551-8. PubMed ID: 16126995 [TBL] [Abstract][Full Text] [Related]
17. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. Rowshani AT; Scholten EM; Bemelman F; Eikmans M; Idu M; Roos-van Groningen MC; Surachno JS; Mallat MJ; Paul LC; de Fijter JW; Bajema IM; ten Berge I; Florquin S J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168 [TBL] [Abstract][Full Text] [Related]
18. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression. Rintala JM; Savikko J; Rintala SE; von Willebrand E Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial. Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289 [TBL] [Abstract][Full Text] [Related]